We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 627

German perspective on new EU clinical trials regulation
  • McDermott Will & Emery
  • Germany
  • October 29 2014

On June 16 2014 EU Regulation 5362014 on Clinical Trials on Medicinal Products for Human Use entered into force. Once it becomes applicable, the

New opportunities for second medical use claims in Germany
  • CMS Cameron McKenna
  • Germany
  • February 20 2015

On 24 February 2014, the German Federal Court of Justice (Bundesgerichtshof, 'FCJ') handed down its decisions Kollagenase I and Kollagenase II (file

Connected health: legal aspects of health apps in Germany
  • Taylor Wessing
  • Germany
  • April 20 2015

In the near future, your smartphone may act as a "portable GP": Analysing the data from a wireless sensor patch on your body to warn you about your

EU pricing & reimbursement
  • Hogan Lovells
  • Belgium, Czech Republic, France, Germany, Italy, Netherlands, Russia, Spain, United Kingdom
  • November 10 2014

This newsletter provides comprehensive overviews of the system of pricing and reimbursement of medicinal products and medical devices in EU Member

International news: focus on compliance - winter 2014
  • McDermott Will & Emery
  • China, European Union, Germany, Global, USA
  • December 2 2014

As regulatory oversight of companiesfrom Sarbanes Oxley and the Dodd-Frank Act to the Foreign Corrupt Practices Act (FCPA) and the UK Bribery

Pharmaceutical trademarks
  • Siebeke Lange Wilbert
  • European Union, Germany
  • August 23 2011

During the last two years, the German courts have decided a number of cases involving pharmaceuticals and medical devices

German FSA releases new Transparency Code
  • Eversheds LLP
  • Germany
  • August 22 2014

German Association FSA "Voluntary Self-regulation for the pharmaceutical industry" ("Freiwillige Selbstkontrolle für die Arzneimittelindustrie"

Privacy & cybersecurity update, issue 3 - October, 2014
  • Jones Day
  • Australia, Brazil, Canada, Russia, Taiwan, USA, Ireland, Italy, Japan, Mexico, Netherlands, New Zealand, Chile, China, European Union, France, Germany, Hong Kong
  • October 15 2014

On August 1, the Federal Trade Commission ("FTC") issued a report on mobile shopping applications. In it, the FTC found that such apps often fail to

Los genéricos y las empresas que les suministran: nueva cuestión prejudicial
  • Abril Abogados
  • European Union, Germany
  • February 22 2014

El tribunal superior de justicia de Dusseldorf (Alemania) ha elevado cuestion prejudicial al Tribunal de Justicia sobre la relacion

Pre-expiry offers to supply after patent term expiry
  • Taylor Wessing
  • Austria, Germany, United Kingdom
  • August 6 2013

Patent infringement by pre-expiry offer to supply a product after the patent has expired is an area of acute difficulty in Austria. In Austria, two